Atara Biotherapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Atara Biotherapeutics Inc
TickerATRA
CIK #0001604464
CUSIP046513107
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address3260 Bayshore Boulevard, Brisbane, CA 94005
Source [EDGAR]
CIK Filing 2011 - 2025
[0001604464] 10-K
[0001604464] 10-Q
[0001604464] 3
[0001604464] 4
[0001604464] 8-K
[0001604464] SC 13D
[0001604464] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Redmile Group LLC Atara Biotherapeutics Inc [2025-05-23] 0.0
Panacea Innovation Ltd Atara Biotherapeutics Inc [2025-05-21] 0.0
Panacea Innovation Ltd Atara Biotherapeutics Inc [2025-02-06] 0.0
Adiumentum Capital Fund I LP Atara Biotherapeutics Inc [2024-05-22] 6.7
Citadel Advisors LLC Atara Biotherapeutics Inc [2024-03-18] 6.4
EcoR1 Capital LLC Atara Biotherapeutics Inc [2023-11-21] 0.9
Wasatch Advisors Inc Atara Biotherapeutics Inc [2023-02-08] 8.8
Goldman Sachs Group Inc Atara Biotherapeutics Inc [2023-02-07] 6.4
State Street Corp Atara Biotherapeutics Inc [2023-02-03] 8.06
FMR LLC Atara Biotherapeutics Inc [2022-02-09] 0.0
Point72 Asset Management LP Atara Biotherapeutics Inc [2021-12-21] 5.1
JPMorgan Chase & Co Atara Biotherapeutics Inc [2021-01-08] 7.3
Maverick Capital Ltd Atara Biotherapeutics Inc [2020-02-14] 9.2
Bridger Management LLC Atara Biotherapeutics Inc [2019-11-01] 5.5
Camber Capital Management LP Atara Biotherapeutics Inc [2019-07-29] 2013.0
Vanguard Group Inc Atara Biotherapeutics Inc [2019-02-11] 6.16
Camber Capital Management LLC Atara Biotherapeutics Inc [2018-01-05] 2013.0
Morgan Stanley Atara Biotherapeutics Inc [2017-12-07] 5.0
Bridger Management LLC Atara Biotherapeutics Inc [2017-04-21] 5.2
Arrowpoint Asset Management LLC Atara Biotherapeutics Inc [2017-02-13] 5.4
BlackRock Inc Atara Biotherapeutics Inc [2017-01-30] 6.0
Redmile Group LLC Atara Biotherapeutics Inc [2016-02-16] 5.36
FMR LLC Atara Biotherapeutics Inc [2016-02-12] 0.0
Amgen Inc Atara Biotherapeutics Inc [2015-04-01] 9.0
Kleiner Perkins Caufield & Byers XV LLC Atara Biotherapeutics Inc [2015-02-17] 12.9
HELU Carlos SLIM Atara Biotherapeutics Inc [2015-02-17] 6.6
DAG Ventures V-QP LP Atara Biotherapeutics Inc [2015-02-17] 9.4
Ciechanover Isaac E Atara Biotherapeutics Inc [2015-02-13] 5.3
Celgene Corp /DE/ Atara Biotherapeutics Inc [2015-02-13] 9.0
FMR LLC Atara Biotherapeutics Inc [2015-02-13] 0.0
Domain Partners VIII LP Atara Biotherapeutics Inc [2015-02-05] 10.6
Baupost Group LLC/MA Atara Biotherapeutics Inc [2014-11-10] 12.86
Form 3/4/5 Filer 2011 - 2025
Nguyen AnhCo
Atara Biotherapeutics, Inc.
Grant-Huerta Yanina
Panacea Innovation Ltd
Huang James
Mallik Ameet
Gallagher Carol Giltner
Heiden William K
Fust Matthew K
Touchon Pascal
Roncarolo Maria Grazia
Green Jeremy
Redmile Group, LLC
Subramanian Nachiappan
Adiumentum Capital Fund I GP LLC
Adiumentum Capital Fund I LP
Ciongoli Gregory Austin
Hyllengren Eric J
Henrich Jill
Murugan Amar
Joshi Manher
Dobmeier Eric
Seidenberg Beth C
Banard Charlene A.
Dupont Jakob
Koppikar Utpal
Renaud Ronald C JR
Baynes Roy D.
Yarema Kristin
Newell Joe
Ciechanover Isaac E.
Berger Dietmar
Kim Mina
Porter Derrell
Marcus Joel S
Haqq Christopher
Soffer Gad
Clark Mitchall G.
McGrath John
Turner Heather D
Kleiner Perkins Caufield & Byers XV, LLC
KPCB XV Associates, LLC
KPCB XV Founders Fund, LLC
Weber Eckard
DAG Ventures V-QP, L.P.
DAG Ventures V, L.P.
Chung Young J.
Pianim Nicholas K.
Goodrich R. Thomas
Williams Greg
DAG Ventures Management V, LLC
Cadeddu John J.
Blair James C
Treu Jesse I
Vitullo Nicole
Schoemaker Kathleen K
DP VIII Associates, L.P.
Dovey Brian H
Halak Brian K
Domain Partners VIII, L.P.
Form 13F Holdings
Firm Period DFND Voting Shares
EcoR1 Capital LLC [2025-06-30] SOLE 573,183 573,183
Redmile Group LLC [2025-06-30] SOLE 441,701 441,701
Vanguard Group Inc [2025-06-30] SOLE 0 189,305
Vestal Point Capital LP [2025-06-30] SOLE 94,085 94,085
Staley Capital Advisers Inc [2025-06-30] SOLE 75,000 75,000
BlackRock, Inc. [2025-06-30] SOLE 70,848 70,848
Acadian Asset Management LLC [2025-06-30] DFND 65,155 65,155
Geode Capital Management LLC [2025-06-30] DFND 60,136 60,136
Marshall Wace LLP [2025-06-30] OTR 0 42,355
State Street Corp [2025-06-30] DFND 25,253 25,253
Citadel Advisors LLC [2025-06-30] DFND 23,003 23,003
Mackenzie Financial Corp [2025-06-30] SOLE 22,514 22,514
GSA Capital Partners LLP [2025-06-30] SOLE 19,591 19,591
FMR LLC [2025-06-30] DFND 16,244 17,156
Renaissance Technologies LLC [2025-06-30] SOLE 16,936 16,936
Morgan Stanley [2025-06-30] DFND 14,802 14,926
Bridgeway Capital Management LLC [2025-06-30] SOLE 14,000 14,000
Northern Trust Corp [2025-06-30] DFND 11,147 11,170
UBS Group AG [2025-06-30] DFND 8,385 8,385
Bank of America Corp /DE/ [2025-06-30] DFND 0 7,688
Raymond James Financial Inc [2025-06-30] DFND 0 4,021
Vanguard Group Inc [2025-06-30] DFND 0 1,456
Royal Bank of Canada [2025-06-30] DFND 1,450 1,450
SBI Securities Co., Ltd. [2025-06-30] DFND 1,404 1,404
Wells Fargo & Company/MN [2025-06-30] DFND 0 951
Jones Financial Companies LLLP [2025-06-30] SOLE 703 703
Osaic Holdings Inc [2025-06-30] DFND 0 610
JPMorgan Chase & Co [2025-06-30] DFND 216 216
Raiffeisen Bank International AG [2025-06-30] SOLE 200 200
Banque Transatlantique SA [2025-06-30] DFND 0 176
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com